CUTOLO, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 79.880
NA - Nord America 9.922
AS - Asia 9.894
Continente sconosciuto - Info sul continente non disponibili 2.165
SA - Sud America 913
AF - Africa 218
OC - Oceania 13
Totale 103.005
Nazione #
IT - Italia 78.193
US - Stati Uniti d'America 9.193
SG - Singapore 4.279
CN - Cina 2.366
VN - Vietnam 1.434
FR - Francia 804
BD - Bangladesh 739
BR - Brasile 518
HK - Hong Kong 387
CA - Canada 262
FI - Finlandia 251
DE - Germania 173
AR - Argentina 151
MX - Messico 141
JP - Giappone 98
IN - India 97
GB - Regno Unito 96
JM - Giamaica 85
ID - Indonesia 73
CO - Colombia 66
EC - Ecuador 65
IQ - Iraq 57
PH - Filippine 54
TR - Turchia 54
CR - Costa Rica 50
ES - Italia 48
ZA - Sudafrica 40
NL - Olanda 38
CH - Svizzera 36
HN - Honduras 35
VE - Venezuela 35
SA - Arabia Saudita 31
GT - Guatemala 29
KR - Corea 29
PK - Pakistan 29
TT - Trinidad e Tobago 28
CL - Cile 27
IE - Irlanda 27
PT - Portogallo 27
NI - Nicaragua 26
TH - Thailandia 26
KE - Kenya 25
SC - Seychelles 25
PY - Paraguay 24
MA - Marocco 23
DZ - Algeria 22
UA - Ucraina 21
EG - Egitto 20
RU - Federazione Russa 20
PL - Polonia 19
IL - Israele 18
MY - Malesia 17
TN - Tunisia 16
PR - Porto Rico 15
SV - El Salvador 15
SE - Svezia 14
AT - Austria 13
HU - Ungheria 13
TW - Taiwan 13
AL - Albania 11
AU - Australia 11
UZ - Uzbekistan 11
NP - Nepal 10
RO - Romania 10
UY - Uruguay 10
JO - Giordania 9
AE - Emirati Arabi Uniti 8
BB - Barbados 8
BO - Bolivia 8
KG - Kirghizistan 8
LV - Lettonia 8
PE - Perù 8
CI - Costa d'Avorio 7
BS - Bahamas 6
DK - Danimarca 6
BE - Belgio 5
BG - Bulgaria 5
LT - Lituania 5
PA - Panama 5
PS - Palestinian Territory 5
AM - Armenia 4
AZ - Azerbaigian 4
BY - Bielorussia 4
EE - Estonia 4
ET - Etiopia 4
IR - Iran 4
LB - Libano 4
MR - Mauritania 4
NG - Nigeria 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AG - Antigua e Barbuda 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
KZ - Kazakistan 3
AD - Andorra 2
AW - Aruba 2
Totale 100.765
Città #
Genova 49.198
Genoa 17.680
Rapallo 5.450
Vado Ligure 4.637
San Jose 2.151
Singapore 2.069
Ashburn 760
Lauterbourg 751
New York 428
Ho Chi Minh City 404
Hong Kong 354
Hanoi 333
Beijing 331
Council Bluffs 315
Santa Clara 272
Helsinki 239
Los Angeles 202
Milan 184
St Louis 180
Bordighera 157
Dallas 124
Rome 124
Frankfurt am Main 120
Chicago 114
Phoenix 111
Tokyo 90
Atlanta 79
Mexico City 79
Boardman 76
Haiphong 66
Naples 64
Buffalo 61
Tianjin 57
Orem 54
Da Nang 53
San Francisco 50
Kingston 47
Philadelphia 43
Toronto 42
São Paulo 41
Washington 40
Miami 39
Houston 38
Montreal 38
Las Vegas 37
Brooklyn 35
Charlotte 35
Denver 34
Quito 34
San José 34
Turin 33
Zurich 31
Columbus 29
Dublin 28
Newark 28
Boston 27
Queens 27
Bari 26
Managua 26
Baghdad 25
City of London 24
Hải Dương 23
Cleveland 22
Florence 22
Guangzhou 22
Nairobi 22
Ninh Bình 22
San Antonio 22
Biên Hòa 21
Nuremberg 21
Amsterdam 20
Guatemala City 20
Palermo 20
Rio de Janeiro 20
Bologna 19
Jacksonville 19
Mumbai 19
Padua 19
Seattle 19
Bogotá 18
Brasília 18
Memphis 18
The Bronx 18
Thái Bình 18
Can Tho 17
Paris 17
Warsaw 16
Chaguanas 15
Figino 15
Johannesburg 15
San Salvador 15
Ankara 14
Birmingham 14
Des Moines 14
Dhaka 14
London 14
Pittsburgh 14
Salt Lake City 14
Shanghai 14
Tel Aviv 14
Totale 88.956
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 560
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. 268
Atlas of Capillaroscopy in Rheumatic Diseases 239
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 239
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 238
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 230
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 219
[CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture] 215
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 214
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice 211
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 207
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 207
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 206
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases 202
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 202
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 201
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 201
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease 199
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. 198
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. 197
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 197
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 196
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 195
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis 194
Steroids and Autoimmunity 193
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 193
Functional study of glenohumeral ligaments. 192
Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition 192
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 191
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. 190
Evolutionary medicine and bone loss in chronic inflammatory diseases-A theory of inflammation-related osteopenia 190
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 189
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 189
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 188
Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal 187
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 186
Correlation between bone quality and microvascular damage in systemic sclerosis patients 185
Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory 184
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? 183
Zinc concentrations in rheumatoid and psoriatic arthritis. Are they relevant to the inflammatory process? 182
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. 182
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 182
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 182
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. 180
Androgens in rheumatoid arthritis: when are they effectors? 180
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 180
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 179
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 179
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 178
Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. 178
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 177
Androgen replacement therapy in male patients with rheumatoid arthritis. 176
Acral localized acquired cutis laxa associated with rheumatoid arthritis. 176
Systemic sclerosis: state of the art on clinical practice guidelines 175
Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. 174
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 174
Raynaud's syndrome in children: systematic review and development of recommendations for assessment and monitoring. 174
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs 173
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. 173
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 173
Pregnancy, cytokines and disease activity in systemic lupus erythematosus 173
Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature 173
Advanced in naifold capillaroscopic analysis in systemic sclerosis 173
Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis. 172
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. 172
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 171
High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography 171
Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients 171
Rheumatoid arthritis: circadian and circannual rhythms in RA. 170
Timing of transition between capillaroscopic patterns in systemic sclerosis. 170
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy. 170
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 170
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies. 170
[Nailfold capillaroscopy and blood flow laser-doppler analysis of the microvascular damage in systemic sclerosis: preliminary results]. 169
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 169
Mapping and predicting mortality from systemic sclerosis. 169
Anti-TNF and sex hormones 168
Androgen status in postmenopausal patients with rheumatoid arthritis. 167
Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis 167
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 167
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 167
Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. 166
A method for counting monosodium urate crystals in synovial fluid 165
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 165
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study. 165
Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients. 165
Mixed connective tissue disease: state of the art on clinical practice guidelines 165
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 164
Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. 164
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 164
[Leishmaniasis in rheumatoid arthritis]. 164
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement]. 164
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 163
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. 163
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity. 163
Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. 162
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 161
Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) 161
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 161
17beta-Estradiol and testosterone influence the mRNA expression and the time course of inflammatory cytokines in activated human monocytic cell line (THP-1). 161
Totale 18.669
Categoria #
all - tutte 333.148
article - articoli 316.116
book - libri 0
conference - conferenze 12.262
curatela - curatele 514
other - altro 374
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.882
Totale 666.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.517 0 0 655 956 198 481 579 2.036 470 792 321 1.029
2022/20236.717 802 246 49 567 1.231 1.153 41 658 1.187 47 650 86
2023/20244.048 183 640 82 364 292 638 255 336 192 75 234 757
2024/202511.462 412 1.057 384 709 1.618 1.115 1.085 1.585 420 671 1.063 1.343
2025/202624.418 2.279 756 1.453 2.247 2.652 2.859 4.121 993 1.915 2.531 1.247 1.365
2026/20275.627 2.961 1.048 1.618 0 0 0 0 0 0 0 0 0
Totale 103.005